> Eli Lilly has released late-stage data showing that Arxxant reduces the loss of vision from diabetes by 40 percent. Report
> Favrille says its experimental therapy for non-Hodgkin's lymphoma missed a secondary endpoint but that researchers are still examining its results for a primary endpoint in a late-stage trial. Report
> Shares of the UK's SR Pharma surged on the news that early testing on an RNAi therapy delivered encouraging results. Report
> A Maryland biotech upstart has garnered $4 million in angel backing to launch its commercial work in developing a new stem cell therapy for cardiology. Report
> ZymoGenetics and Serono released positive data from their Phase Ib trial of atacicept for lupus. Release
> Shares of Denmark's LifeCycle Pharma jumped 10 percent during its market debut. Report
> Nordic Biotech and pSivida have inked a $26 million pact for funding the eye therapy Medidur. Release
> The FDA has announced plans to tighten up regulations governing several medical devices, including stents, pacemakers, implantable defibrillators and other medical devices it regulates. Report
> Pharmaceutical industry vendors are suing to get a New Hampshire law thrown out which they claim unconstitutionally restricts their use of physician-identifiable prescription information. Report
And Finally... One in three U.S. hospitals, including top cardiac centers, do not follow recommended procedures in caring for heart attack victims. Article